FDA Approved: TALTZ — Original Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved the original Biologics License Application for TALTZ (ixekizumab) from Eli Lilly for the treatment of plaque psoriasis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TALTZ (IXEKIZUMAB)

Snippet

ORIG AP for TALTZ (IXEKIZUMAB)